• Non ci sono risultati.

Down DNA

N/A
N/A
Protected

Academic year: 2021

Condividi "Down DNA"

Copied!
5
0
0

Testo completo

(1)

Genetics

Comparative mapping of DNA markers from the familial Alzheimer disease and Down syndrome regions of human chromosome 21 to mouse chromosomes 16 and 17

(restrictionfragment lengthpolymorphism/genetic linkageanalysis/recombinantinbredstrains/interspecificbackcross)

SHIRLEY V. CHENG*, JOSEPH H. NADEAUt, RUDOLPH E. TANZI*, PAUL C. WATKINSt,

JAYASHREE JAGADESH*, BENJAMIN A. TAYLORt, JONATHAN L. HAINES*, NICOLETTA SACCHI§,

AND

JAMES F. GUSELLA*

*Neurogenetics

Laboratoiy,

MassachusettsGeneralHospital andDepartmentof Genetics,HarvardMedicalSchool,Boston,MA 02114;tTheJackson Laboratory, BarHarbor, ME04609;tIntegrated Genetics, Inc., 31 New YorkAvenue,Framingham, MA01701; and§Laboratoryof Molecular Oncology, National CancerInstitute,Frederick,MD 21701

Communicatedby ElizabethS.Russell, April 18, 1988

ABSTRACT Mousetrisomy 16 has been proposed as an animal model of Downsyndrome(DS),sincethischromosome contains homologues of several loci from the q22 band of human chromosome 21. The recent mapping of the defect causingfamilialAlzheimerdisease(FAD)and the locus encod- ing the

Alzheiner

amyloid (3 precursor protein (APP) to human chromosome 21 hasprompteda moredetailed examinationof the extent of conservation of thislinkage group between the two species. Using anonymous DNA probes and cloned genes

from

humanchromosome 21 in a combination of recombinantinbred and interspecific mouse backcross analyses, we have estab- lished thatthelinkagegroupshared by mouse chromosome 16 includes notonly the critical DSregionof humanchroniosome 21but alsothe

APP

gene andFAD-linked markers. Extending from the anonymous DNA locus D21S52 toETS2, the linkage map of sixloci spans 39% recombination in man but only 6.4%

recombination in the mouse. A break insynteny occurs distal toETS2, with thehomologue ofthe humanmarker D21S56 mapping to mouse chromosome 17. Conservation of thelinkage relationships ofmarkersin the FAD region suggests that the murinehomologue of the FAD locus probably mapstochro- mosome 16and that detailedcomparison ofthecorresponding region in both species could facilitate identification of the primary defectinthis disorder.The break in synteny between the terminal portion of human chromosome 21 and mouse chromosome 16indicates, however,thatmousetrisomy16may not represent a complete model of DS.

Human chromosome 21, the smallest autosome

comprising

1.9% of thegenome, hasbeenextensively characterized by

cytogenetic

approaches and molecular

techniques, including

thedevelopment ofphysical andgeneticmaps(1).A

primary

impetus forthiseffort is the role of chromosome21inDown syndrome

(DS),

one of the mostcommon causesof mental retardation (2). Karyotypic analyses of cases of partial trisomy21haveindicated thatonlypartofthechromosome, band 21q22, is required for full manifestation of the DS phenotype (3-8). Thoughthisregion probablycontains afew hundred genes that could contribute to the disorder, an unequivocalcausal role hasnotyetbeen established for any individual locus.However, since thesyntenicrelationshipof several candidate genes such as superoxide dismutase (SOD

1),

the ets-2 protooncogene(ETS2),phosphoribosylgly- cinamide synthetase (PRGS), and the interferon receptors (IFNAR andIFNBR) has apparentlybeenconserved in the

mousegenome,mousetrisomy 16 has been usedas ananimal model of DS(9, 10).

Interestinhumanchromosome 21 hasincreased withthe recentlocalizations ofthedefectcausingfamilial Alzheimer disease(FAD) and the gene (APP)

encoding

the precursorfor amyloid

,8

proteintothe proximalhalf of 21q (11, 12). FAD is the autosomal dominantly inheritedform of the common late-onset neurodegenerative disorder that results in the gradual and devastating impairment of memory and cogni- tion.Amyloidf3protein isamajorcomponentof the neuritic plaques seen in sporadic and inheritedformsof Alzheimer disease (AD) and in DS. To assess the potential utility of mousechromosome16intheinvestigationof ADand DS, we have compared the genetic linkage relationships of the murine homologues of a number of loci spanning 21q, including the genes APP, SOD), and ETS2 and several cross-hybridizing anonymous DNA loci.

METHODS

Mice.

Progenitor

inbredmousestrains

AKR/J, C57BL/6J, C3H/HEJ,, C57L/J,

and

DBA/2J

and therecombinant inbred (RI) setsAKXD, AKXL, BXD, and BXH werepurchased fromTheJacksonLaboratory. Recombination estimatesand 95% confidence intervals (CIs) for the RI analysis were determinedfrom Silver (13).

Interspecific Backcross.

C57BL/6J

- Re

Trl

+ + females crossedtoMusspretus[Spain]malesandF1hybrid females werebackcrossedto

C57BL/6J

males.GenomicDNAsfrom each backcross progeny were prepared from samples of spleenandliverasdescribed(14).Approximate95% CIson the estimated recombination frequency were calculated as described(15).

DNA Probes andSouthernBlotHybridization. The human chromosome21 probestested for

cross-hybridization

were pGSE9

(D2JS16), 511-lH/511-2P

(D21S52), pPW228C

(D2151),

pPW245D VD21S8), FB68L and HL124

(APP),

pSG1-10

(SOD)),

524-5P (D21S58), H33

(ETS2),

520-1OR

(D21S56),

pGSE8

(D215J),

pPW231C

(D2153),

and pPW242B

(D21S7)

(12, 16-21). DNAprobeswereprepared andlabeledfor hybridizationto Southern blots

of

genomic DNAdigested with 10-35restrictionenzymes asdescribed (22, 23).

GloTyping. The BXDRI strainswerecharacterized with respect to quantitative variation in erythrocyte glyoxylase

Abbreviations: DS, Down syndrome; FAD, familial Alzheimer disease; RFLP, restriction fragment length polymorphism; SDP, strain distributionpattern;CI,confidenceinterval; RI,recombinant inbred.

6032 Thepublicationcostsof this articleweredefrayedinpartbypagecharge payment.This articlemusttherefore beherebymarked"advertisement"

inaccordance with 18 U.S.C. §1734solelytoindicate this fact.

(2)

activity, which results fromacis-acting element thatmapsto theGlo-i structural genelocus (24). To facilitate classifica- tion, eachBXD strainwas outcrossedtothe SWR/J strain, which bears theGlo-lb electrophoretic variant. The relative contribution of theGlo-la allele from the BXD straintothe Glo-Pa/Gbo-lb allozymepatternwascomparedto(SWR/J x

C57BL/6J)F1 and (SWR/J x DBA/2J)F1 controls. RI strains with relatively little GLO-lA homodimer were judged to

carrytheC57BL/6J allele and strains with relativelymoreof the GLO-lA homodimerwerejudged tocarrythe DBA/2J allele.

RESULTS

To define the murine counterparts for the DS and FAD chromosomal regions, probes for human chromosome 21 DNA loci spanning 21q were employed forrestriction frag- ment length polymorphism (RFLP) linkage analysis in the

mouse.The murine homologues for SOD] and ETS2, Sod-i and Ets-2, respectively, have previously been localizedtothe distal portion ofmouse chromosome 16. These human loci from 21q22 are considered markers for the region of chro-

mosome21 associated with manifestation of the DS pheno- type (9, 10).

The linkage relationships ofthe murine homologues de- tected bythe human chromosome 21 probes were initially assessedby using foursetsofRIstrains(25), eachderivedby inbreeding the progeny of a cross between two parental inbred strains.Comparison of thestraindistributionpatterns (SDPs) of the genotypes for any two loci with differing parental genotypes provides a measure of their linkage relationship, thereby allowing the rapid chromosomal local- ization ofnewloci relative tothose previously typedinthe

sameRI sets.

Each human DNA probewas checked by Southern blot analysis forits degree ofcross-hybridization toDNA from theprogenitorinbredmousestrains. Thepotentialforusing

anonymous human DNA RFLP markers for interspecies mapping dependson theextentofdivergencein thehomol-

ogousDNAsequencesbetween thetwospecies. Ingeneral, codingsequenceswould beexpectedtoshow lessdivergence than noncoding sequences. Therefore, anonymous DNA markers that show cross-hybridization are more likely to

containcodingsequences.Onlysevenofthechromosome12 DNA markers tested (see Methods) showed reproducible cross-hybridizationtomouseDNA: thegenes SOD),ETS2, and APP and the anonymous DNA sequences D21S16, D21S52, D21S56, andD21S58.

Subsequently, the cross-hybridizing markers were

screenedfor RFLPs byhybridizing under nonstringentcon-

ditions to Southern blots containing up to 35 restriction

enzyme digests of genomic DNA from a series of inbred

mousestrains: A/J, AKR/J, C57B3L/6J, C3H/HeJ,C57L/J, DBA/2J, and SJL/J. With the exception of ETS2 and D21S58, the markers revealed RFLPs (Table 1) in the progenitorinbred strains making them useful for analysis of

some RI lines with representativesof the DS (SOD),APP, D21556) and FAD regions (D21i16, D215S2). An example of the polymorphic cross-hybridizing Southern blot signal de- tected byahuman DNA probe is illustrated in Fig. 1A, where

acDNAprobe for APP revealedaMsp I RFLP between the C57BL/6J and the DBA/2J progenitormouse strains.

For each markerdisplaying a RFLP in the mouse, geno- typesof individual RI strains from the appropriate RI sets (AKXD, AKXL, BXD, and BXH) were determined. The SDPsfor these markersarepresentedinTable2.Comparison of thesetothe SDPsforabank of 400previously mapped loci

wasperformedtoassign chromosomallocations for the DNA markers.For theanonymoushuman DNAmarkers,wehave used the human locus symbol to identify the homologous murine locus. For the homologue of the APP locus, we propose thesymbol App.

The results of the RIanalysisinthe BXD andAKXDsets revealed that App and D21J16 are closely linked with six differences among 49 lines, corresponding to a genetic separation of3.7% recombination (CI = 1.6-9.9). However, these markerseachdisplayed eight differenceswith the SDP for Sod-i in26 strainsof theBXD setof RI strains, though theirhuman homologues display relatively close linkage. It

wasnotpossible toexclude these loci from chromosome 16 because of thepaucity of previously assigned markers for this chromosome. Furthermore, App, D21S16,and D215S2gave

negative linkage scores for markers on all other chromo-

somes, making it impossible to assign their chromosomal location.

Table 1. RFLPsused in RI mousestrainsandinterspecific backcross linkage analysis

Inbredstrains Interspecificbackcross

Restriction RIstrain Polymorphic Constant Restriction M. spretus C57BL/6J

Locus enzyme progenitors* fragments,kb fragments,kb Locus enzyme fragments, kb fragments,kb

D21S16 BgiII A, B 4.6 - D21S16 XbaI 8.2 3.7

D 3.3 App XbaI 7.8 3.8

BamHI A, B 18.0 D21S52 Xba I 10.1 4.4

D 7.3

Sod-i

PvuII 4.3 8.6, 7.0, 6.4

App MspI D, H 4.0 3.9, 2.7,2.0, D21S58 Taq I 3.8, 1.8 2.3, 1.2

0.6,0.4

A,B 2.4 3.9, 2.7, 2.0, Ets-2 BamHI 3.2 8.0

0.6,0.4

D21S52 Taq I A 3.5

L 2.3

Pvu II L 6.3

A 3.2

Sod-i PstI B, L 15.0 5.6, 5.8

A, D 9.5 5.6,5.8

BamHI B,L 10.5 19.0

A, D 8.0 19.0

D21S56 Xmn I A, D, H 9.4 18.0

B,L 8.0 18.0

kb, Kilobases.

*A,AKR/J;B,

C57BL/6J; D,

DBA/2J;H, C3H/HEJ;L,C57L/J.

(3)

A

Msp I

2 3 4 5 6 7 8 9

0.a &:

.23456789

q..*Jo fo Allele D

\Allele B 'm 40* t1

9 9, 9.. -c

.. D' -C '*^ v *~* - -C

B Xba I

2 3 456 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

u*Mg- -Allele S FIG. 1.

Segregation

of RFLPs intherecombinant

.*.--be--** * *ABE ~-Allele S

inbredstrains andtheinterspecificmousebackcross.

RepresentativeautoradiogramsareshownforMspI

*

-|i,,

Allele B (A)and Xba I(R)

digests

ofmouseDNA

hybridized

tothe human APP cDNA probesHL124andFB68L, respectively. (A) Lanes 1-9, mouse DNAsofasubset of theBXDRI strains.(B) Lanes1-21,DNAsfrom some ofthe backcross progeny ofthe interspecific cross. Alleles for the progenitorstrains C57BL/J,

-Allele B DBA/2J, andM. spretus[Spain]areshown as generic symbols B, D, and S respectively. C represents a constantDNAband.

The RI analysis provided achromosome assignment for D21S56,

which

showed significant linkage with loci in the proximal regionof chromosome17.D21S56 istightly linked tothequantitative variant oftheglyoxylase-1(Glo-i) locus, with norecombinants in 26informativeRIstrains. Similarly, D21S56 maps5.4% recombination (CI = 2.6-12.7)distalto Hba-4ps, the hemoglobin a-chain pseudogene locus

(nine

differences in 55 RIstrains), 0.6% recombination (CI =0.02-

3.8)

from

Pim-),

the preferred

integration

site for minkcell focus-forming viruses (one difference in 43 strains), 1.0%

recombination

(CI

= 0.03-7.0) from

Crya-J,

the lens a-

crystallin

locus (one difference in 26 strains),'and 2.6%

recombination- (CI = 11-7.0) proximal toH-2, the major

histocompatibility

locus (five differences in56strains) (26- 31). The data are most consistent with the gene order

Hba-4ps-(Glo-i, D21S56)-Pim-1-Crya-J-H-2.

However, since theplacement of

GM-i

andD21S56

proximal

toPim-l is based on a single crossover strain, alternative'arrange- ments are

possible.

Although RI analysis is a rapid method for detecting genetic

linkage,

classical backcross

analysis provides

greater sensitivity for larger

recombination

fractions and a more reliablemeansof

determining

therelative order of thevarious markers. Therefore, we used an

interspecific

backcross between

C57BL/6J

andM.spretus

[Spain]

to

firmly

establish that all of the

cross-hybridizing

loci exceptD21S56 resideon chromosome16and todetermine their map order. Theuse

of

an

interspecific' backcross,

which in this case involved breeding

C57BL/6J

maleswiththe'F1 female offspring ofan interspecific cross between

C57BL/6J

and M.

spretus

[Spain], is'more efficient than one

involving 'only

inbred strainsdue to theincreased likelihoodof

finding

segregating RFLPs foreachmarkerlocus(32). RFLPs

distinguishing the

Table 2. RISDPs formousehomologuesof humanchromosome21loc

parental mouse strains for each of the cross-hybridizing probeswereidentified by screening with up to 10restriction enzymes (Table 1) and were subsequently used forlinkage analysisusingacombination of 63 progeny

of

thebackcross (Fig.' 1B and Table 3).

Significant linkage was detected among all six loci signi- fying the conservation of an

extended''syntenic

group on mouse chromosome 16 and

hum'an'chromosome

21. One crossover separated Ets-2 from all the other loci. Three additional crossovers split the loci into two groups: (Ets-2,

Sod-], D2JSS8)

and

(App, D2JSJ6, D21S52).

Taken

together,

these data suggest the order (App,

D2iS16, D21S52)- (D2iS58, Sod-i)-Ets-2

(Table 3). This linkage group spans 6.4% recombination

(CI

= 2.0-15.0) with

Ets-2

being

1.6%

recombination

(CI

= 0.01-8.0) from

the

(D2iS58,

Sod-i)

cluster.

The4.8% recombination observed between

Sod-i

and App inthe backcross contrasts with the inabilitytoprovelinkage of these markers' by the less-sensitive RI analysis. At this genetic distance, wewould have expected4of26 RIstrains to

4iffer

between the twoloci, corresponding to-a recombi- nationfrequency of5.0%, with 95% confidencelimits of 1.2%

to

18.3%.

Theobserved

eight

differencesinthe SDPs

predict

arecombination frequency of 14.3%, which is well within theseconfidence limits. However, although' theRI dataare consistent with the backcross

analysis,

it is not

by

itself sufficient toprovelinkage.

Similarly,

the estimate of

3.7%

recombination between App and

D21SI6

from theRIanalysis appearstobeat odds

with

the failuretodetect anycrossovers in 63 backcross progeny. However, the

probability

of suchan occurrence is about 9% if the recombination estimate is accurateandashighas50%if thelowerconfidence limitof this estimate is the truie value.

9 10 11 12 13 14 15 16

A DA A DD A A

AD A A DA A A

12 13 14 16 17 19 21 24

A LA A AA L L

AL L A LA L L

LA L L LL A A

9 11 12 13 14 15 16 18

B DD B D'DD B

B D B B D D D B

DD B B DD B B

D D B B B B D D

DD B B B B DD

8 9 10 11 12 14 19

H B B HH B H

B B B B HH B

17 18 20 21 22 23 24 26

D AA D A A D D

D A A D A A D D

25 28 29 37 38

A L A

A A AA A

L L L L A

19 20 21 22 23 24 25 27

D D B B D D D D

D D D B D D D D

D D B B B D D D

B B D D B D D B

B B D D B D D B

27 28

D A

D A

28 29 30 31 32

B D B B D

B D B B D

D D B B B

D B D D D

D B D D D

Foreach RIstrain,thesymbolshownindicates thepresenceofanallelecharacteristic ofone ortheother of theprogenitorsfrom whichthe strains werederived(A, AKR/J;B,C57BL/6J; D, DBA/2J;H, C3H/HEJ; L, C57L/J).

AKXDstrain D21S16 App AKXLstrain

Sod-1 D21S52 D21S56 BXDstrain

D21S16 App Sod-i D21S56 Glo-i BXHstrain

App D21S56

1 2

D D

D D

5 6

A A

A L

L A

1 2

B D

13D

B B

D B

D B

2 3

B B

H H

3 78

D DD

A DD

7 89

A LL

L LL

LA L

5 68

B BD

D BB

B BB

DD B

DD B

4 67

B BH

B HH

(4)

Table 3. Interspecificbackcross linkage: allelic combinations inheritedfrom theF1parent

Allelic combination Loci n

D21S16 Sod-i Ets-2

D21S52 D21S58*

App

Parental B B B 23

S S S 36

Recombinant B B x S 0

S S x B 1

B x S S 2

S x B B 1

Total 63

*Due tolackof DNA, D21S58 wastypedin 58ofthe

F1

progeny.The five mice not typed included four showing no recombination between any of the other markers and one of the "B S S"

recombinant type.

Acomparisonof theinterspecificmouselinkage map with the human femalelinkage map (refs. 17, 33;J.F.G., unpub- lisheddata) showsthe extent of thesyntenic region shared by the twospecies (Fig. 2). The order of thelociin the mouseis consistent with the established order of the human loci extending from the 21q11 band through 21q22.3: (D21S52,

D21S16)-APP-SODJ-D21S58-ETS2,

thereby demonstrating linkageas well as syntenyconservation. In man, however, the linkage group spans a much larger genetic distance of

=39% recombination.Therelativecompression of the syn- tenic group in the mouse is dueto a lack of recombination between D21S16 and App, whose homologues display 16%

recombination in the human female, and to much tighter linkage ofSod-i and Ets-2 than their human homologues. By contrast, thelinkagedistance between theamyloid precursor proteingene andthesuperoxide dismutase locus is relatively similarin both species. Results ofthe RIanalysis givinga genetic distance of 3.7% recombination (CI = 1.6-9.9) between App and D21S16 suggest that apparentcompression

4

Centroamere

4.8

1.6

4

Centromere

FD21S16--

D21S52

_App __1

__ ~~~~16

_ 5

_Sod-1i- _-

LD21S58- 17

LEts-2-- 29

Mouse Chromosome 16

I

TD21S52D21S16SOD1D21S58APP

IL

ETS2D21S56

Human Chromosome 21 FIG. 2. Comparison of the syntenic linkage maps of human chromosome21 andmouse chromosome16. Theillustratedmouse

genetic linkagemapofchromosome16wasconstructedby using the interspecific backcross data for comparison with the previously establishedlinkagemapof humanchromosome 21(17,33). Genetic distance is given as recombination frequency. Since sex-specific differences in recombination frequency have been observed on

human chromosome 21, the map displays the recombination fre-

quencyforhuman female meioses (allF1 animals inthe backcross

werefemale).Therelative order of loci within brackets isnotknown.

of the interspecific linkage map in this particular region could be due in some degree to the interspecific nature of the backcross.

In the human, the frequency of recombination on 21q increases dramatically toward the telomere (17, 33), resulting in an estimated 29% recombination between ETS2 and D21S56, both located in the terminal 21q22.3 subband.

Within thisregion thereisabreakin synteny with the mouse, sinceD21S56 mapsunequivocally to mouse chromosome 17.

DISCUSSION

Mapping of the human andmousegenomes hasrevealedthe existence ofconservedlinkage relationshipsformanygenes, withsyntenic stretches averaging about 8.1 + 1.6centimor- gansin the mouse (34, 35). Consequently, the murine homo- logues of human genes associated with specific genetic disordersmayoftenbe present in aconserved linkagegroup ofsignificant size, creatingthe potential forgeneratingnew insights into the human disorder by detailed comparative analysis of the homologous mouse region. For disorders involving genedosage, such as DS, the development ofan accurate mousemodel also becomes a possibility. Previous studies have established that mouse chromosome 16contains somegeneswhose human homologues reside in 21q22, the critical DS region of chromosome21,and haveledtodirected attempts to produce mice with trisomy 16. These do not surviveaslive-bornanimals but dodisplaysomephenotypic features reminiscent ofthe human disorder(9).

Recent molecular genetic investigations have also impli- cated chromosome 21 in AD, a common late-onsetneurode- generative disorder producing progressive dementia. The defectcausingtheinheritedform of AD has beenassigned by linkage analysistochromosome 21 (11). In addition, the gene encodingthe precursoroftheamyloid, protein observedin thesenileplaques ofADhasbeen cloned andmappedtothis autosome (12).Thefactthat aged DSpatients alsodevelop AD-likeneuropathology suggests that AD may involve over- expression ofa genein theproximal portionof21q.

Toexplore thepotential formousetrisomy 16 to act asa modelofDS and AD, we haveexpanded andconstructed a detailed linkage mapfor the region ofsyntenywith human chromosome 21.Overall, loci spanningatleast 39%recom- bination ofthelongarmofhuman chromosome 21 are present on mouse chromosome 16. The three identified genes in- cluded in theanalysis,APP, SOD], andETS2, alllie in the region ofchromosome 21 associated withmanifestation of the DSphenotypeand are present in the same relative order on mouse chromosome 16. Consideringthepreviously mapped biochemicalmarkers PRGS, IFNAR, and IFNBR,sixgenes have now been mapped to these homologous chromosome regions.

Theinclusionof anonymous DNA sequences in thelinkage analysishas revealed that theregionofhomologyextendsto

D2JS16

and D21S52, markers linked to FAD, raising the possibility that mouse chromosome 16 contains a normal homologue of the FAD locus. Identification of coding se- quences ingenomicDNAis oftenfacilitated by assessingthe relative degree of conservation of particular sequences be- tween manand mouse(36).Detailed molecularcomparisonof corresponding mouse and human regions surrounding the disease gene might therefore hasten identification of the primary defectin FAD.

Inthemouse, theshared loci retain the same order as inthe human butspan just6.4% recombination. Evenallowing for general differences in recombination frequency in the two species, this number is still surprisingly low. A similar apparent condensation of thegeneticmap has beenreported byReeves etal. (37), who used a crossbetween the inbred Mus musculus domesticus (BALB) and the wild-derived

(5)

subspecies Mus musculus musculus (Czech II) to estimate thegeneticdistance between Sod-i and Ets-2. These inves- tigators observed only one crossover in 86 chances when (Czech II x

BALB/cPt)Fl

females were backcrossed with Czech II males. When thesamedistancewasestimated from a backcross involving two inbred strains [(BALB/cBy x CBA/J) x BALB/cByI,five recombinationsweredetected in 61 events(37).Thepresenceof a small inversioninvolving one of the flanking markers could have the effect of sup- pressing recombination without obviously changingthegene order (14, 38). An alternativeexplanation is thatthe region betweenD21S16and APP in the human contains additional DNA sequences not present on mouse chromosome 16, thereby increasingthe relativegeneticdistance between the twoloci. This would haveprofound significancefor the use oftrisomy16 as a model ofDS,since some of thisadditional material on chromosome 21 might contribute to the DS phenotype.

The conserved linkage group does not involve the entire 21q arm, as there is a break insyntenydistaltoETS2,with thehomologue of D21S56 mappingto mousechromosome 17.

Recently, twoother loci from the terminalregionof21q22, CRYA, encoding lens crystallin aA (29, 39, 40),and CBS, encoding cystathionine f3-synthetase (41), have been re- portedtohave mousehomologuesin theproximal portionof mouse chromosome 17, placingthemclose toD21S56. This suggeststhat somegenesassociatedwiththe DSphenotype may nothave homologueson mouse chromosome16. Tris- omy for this mouse chromosome may not,therefore, provide acomplete modelfor the human disorder,and the effectof increaseddosageforgenesfrom theregionof chromosome 17 homologous to human 21q22warrantsinvestigation.

WethankKarenGriffin for assistance in thetypingof thispaper and Gordon Stewart and Robert Hallewell forDNA probes. This workwasfundedby National Institutes of Health GrantsNS20012, GM32461, GM39414, and AG06865. S.V.C. received afellowship from the National Huntington's Disease Association. J.F.G. is a SearleScholar of theChicagoCommunityTrust.

1. Watkins, P.C., Tanzi, R. E., Cheng,S.V. & Gusella,J. F.

(1987)J.Med. Genet.24, 257-270.

2. Smith, G. F., ed. (1985) MolecularStructureoftheNumber21 Chromosome and Down Syndrome (N.Y. Acad. Sci., New York).

3. Niebuhr,D.(1974)Humangenetik2,99-101.

4. Williams, J.D., Summitt, R. L., Martens,P. R. &Kimbrell, R. A.(1975)Am. J. Hum.Genet. 27,478-485.

5. Chen, H.,Tyrkus, M. &Woolley, P. V.,Jr. (1976) Excerpta Med. Int.Congr. Ser.397, 116(abstr.).

6. Hagemeijer,A.&Smit,E. M. E.(1977)Hum.Genet.38,15- 23.

7. Sinet,P.M.,Couturier,J.,Dutrillaux,M. B.,Poissonnier, M., Raoul,O.,Rethore,M.O.,Allard, D., LeJeune,J.&Jerome, H.(1976) Exp. CellRes. 97,47-55.

8. Hamerton,J. L.(1981)inTrisomy21,eds.delaCruz,F. E.&

Gerald,P.S.(UniversityParkPress,Baltimore), pp.99-107.

9. Reeves,R. H.,Gearhart,J. D.&Littlefield,J. W.(1986)Brain Res.Bull. 16,803-814.

10. Lalley,P.A., O'Brien,S.J.,Creau-Goldberg, N.,Davisson, M.T.,Roderick,T. H.,Echard,G.,Womack,J. E.,Graves, J.M., Doolittle, D. P. &Guidi, J. N. (1987) Cytogenet. Cell Genet.46, 367-389.

11. St. George-Hyslop, P.H., Tanzi, R.E., Polinsky, R.J., Haines, J.L., Nee, L., Watkins,P. C., Myers,R. H.,Feld- man, R.G., Pollen, D., Drachman, D.,Growdon, J., Bruni, A., Foncin, J.-F., Salmon, D., Frommelt, P.,Amaducci,L.,Sorbi, S., Piacentini, S., Stewart, G.D., Hobbs,W.J., Conneally, P. M. &Gusella,J. F. (1987)Science235,885-890.

12. Tanzi,R. E.,Gusella,J. F.,Watkins,P.C.,Bruns,G. A.P., St. George-Hyslop, P., van Keuren, M. L., Patterson, D., Pagan,S., Kurnit, D. M. & Neve, R. L. (1987)Science235, 880-884.

13. Silver,J.(1985)J. Hered.76, 436-440.

14. Nadeau, J. H., Philips, S.J. & Egorov, I. K. (1985) Genet.

Res.45, 251-264.

15. Conneally, P. M., Edwards, J. H., Kidd, K. K., Lalouel, J. M., Morton, N., Ott,J. &White,R.(1985)Cytogenet.Cell Genet.40, 356-359.

16. Stewart, G. D., Hams, P., Galt, J. &Ferguson-Smith, M. A.

(1985) Nucleic AcidsRes. 13,4125-4132.

17. Watkins,P.C., Tanzi,R. E., Roy, J.,Stuart, N.,Stanislovitis, P.&Gusella,J.(1987) Cytogenet.CellGenet.46,712(abstr.).

18. Watkins, P.C., Tanzi,R. E., Gibbons, K.T.,Tricoli,J. V., Landes, G., Eddy, R., Shows,T. B. & Gusella, J. F. (1985) Nucleic AcidsRes. 13,6075-6088.

19. Tanzi, R. E., St. George-Hyslop, P.H., Haines, J. L., Po- linsky,R.J.,Nee, L.,Foncin, J.-F., Neve,R.L.,McClatchey, A.I., Conneally, P.M. & Gusella, J. F. (1987) Nature (London)329,156-157.

20. Hallewell, R., Masiarz, F. R., Najarian,R.C., Puma,J. P., Quiraga, M.R., Randolph, A., Sanchez-Pescador, R., Scan- della, C.J., Smith, B., Steimer, K. S. & Mullenbach, G.T.

(1985) Nucleic AcidsRes.13,2017-2025.

21. Watson, D. K., McWilliams-Smith, M.J., O'Brien, S. J., Duesberg,P. H.&Papas,T.S.(1985)Proc.Natl. Acad.Sci.

USA82,7294-7298.

22. Feinberg, A. P.& Vogelstein, B. (1983) Anal.Biochem. 137, 266-267.

23. Gusella,J. F.,Varsanyi-Breiner,A., Kao, A., Jones,C., Puck, T.T., Keys,C., Orkin,S.& Housman,D.(1979)Proc.Natl.

Acad. Sci. USA76, 5239-5243.

24. Rubenstein,P.&Vienne,K.(1982) Biochem. Genet. 20,153- 163.

25. Taylor,B. A. (1978) in OriginsofInbred Mice, ed. Morse,H.

(Academic,NewYork), pp.423-438.

26. Meo,T., Douglas,T. &Rijnbeek, A. M.(1977)Science198, 311-313.

27. D'Eustachio, P., Fein, B., Michaelson, J. & Taylor, B. A.

(1984)J.Exp. Med. 159,958-963.

28. Mann, E., Elliot, R. W. &Hohman, C. (1984) Mouse News Lett.71,48.

29. Skow,L. C. &Donner,M.E. (1985)Genetics110, 723-732.

30. Bucan, M., Herrman,B. G., Frischauf,A. M.,Bautch,V. L., Bode,V., Silver,L. M.,Martin,G.R. &Lehrach,H.(1987) Genes Dev. 1,376-385.

31. Nadeau,J. H. &Phillips, S.J.(1987)Genetics117,533-541.

32. Robert, B., Barton, P., Minty, A., Daubas, P., Weydert, A., Bonhomme,F., Catalan, J., Anazottes, D., Guenet, J.-L.&

Buckingham,M.(1985)Nature(London)314,181-183.

33. Tanzi, R.E., Watkins, P.C., Gibbons, K., Faryniarz, A., Wallace, M., Hallewell, R., Conneally,P. M.&Gusella,J. F.

(1985) Cytogenet. CellGenet.40,760(abstr.).

34. Nadeau,J. H. &Taylor, B. A.(1984)Proc. Natl.Acad.Sci.

USA81,814-818.

35. Nadeau,J. H. &Reiner,A. H.(1988)inGeneticVariantsand StrainsoftheLaboratory Mouse,eds. Searle,A. G. &Lyon, M. F.(Oxford Univ.Press, Oxford).

36. Monaco,A. P., Neve, R. L., Colletti-Feener, C., Bertelson, C.J.,Kurnit,D. M.&Kunkel,L. M.(1986)Nature(London) 323,646-650.

37. Reeves,R.H., Gallahan, D.,O'Hara, B. F., Callahan, R. &

Gearhart,J. D. (1987) Cytogenet. Cell. Genet.44,76-81.

38. Herrmann, B., Bucan, M., Mains, P. E., Frischauf, A. M., Silver,L. M.&Lehrach,H.(1986) Cell 44,469-476.

39. Quax-Jeuken, Y., Quax, W., Van, G., Khan, M. & Bloe- mendal,H.(1985)Proc.Natl. Acad. Sci. USA82,5819-5823.

40. Kaye,N.W.,Church,R.L.,Piatisorsky,J.,Petrash,J. M.&

Lalley,P. A. (1985)Curr.EyeRes.4,1263-1268.

41. Munke, M., Kraus,J. P.,Ohura,T.&Francke,U.(1988)Am.

J. Hum. Genet.42,550-559.

Riferimenti

Documenti correlati

The Musée de l’Orangerie knows that they cannot compete with their bigger partner, and so they have found their way to face the market: is it possible to see how effective has

helix of the N-terminal domain of apoCaM undergoes large amplitude nanosecond motions 58. This indicates a considerable dynamic flexibility of the first helix of the N-terminal

[Z] Ma v’è una questione che, per la filosofia, è sempre aperta (anche nella tradizione precedente all’avvento della relatività), e che sembra invece presupposta in

commonly used for forensic samples, to obtain human autosomal DNA and X chromosome short tandem repeat profiles from the digestive tract of Chrysomya albiceps

Our goal was to evaluate the mRNA of 13 genes involved in different DNA repair pathways (base excision, nucleotide excision, homologous recombination, and Fanconi anemia) in

(3) Le condizioni sulle quali un qualsiasi sistema vero-funzionale può essere interpretato come un calcolo di proposizioni sono due: (a) I valori di verità devono rappresentare

These oligos named antimiR can target miRNAs at different stages of their biogenesis or block miRNAs activity by binding the mature miRNA sequence or by targeting the miRNA binding

Study Participants Stimulation techniq ue Target area Study design Frequency/Duration Outcome Follow-up Results repetitive Transcranial Magnetic Stimulation (rTMS) [71] 39